Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
In conclusion, until better noninvasive markers for liver fibrosis are developed and validated for HIV-HCV coinfected patients, noninvasive serum markers should be used carefully in this population.
PMID: 31320163 [PubMed]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
More News: Brazil Health | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis C | International Medicine & Public Health | Laboratory Medicine | Liver | Statistics | Study | Urology & Nephrology